Peter Ebeling

Medicine (RMH/WH), University of Melbourne, Australia

Peter Ebeling is Professor and Chair of the Department of Medicine at Western Hospital, Melbourne. He also heads the Department of Endocrinology there.

Professor Ebeling's research interests include public health issues related to vitamin D deficiency; the pathophysiology and management of post-transplantation osteoporosis, particularly following bone marrow transplantation; the genetics and treatment of osteoporosis in men; the efficacy and safety of vertebroplasty and the clinical utility of biochemical markers of bone turnover.

He co-chairs of the Australian Musculoskeletal Quality Improvement Programme and is past President of the Australian and New Zealand Bone and Mineral Society. Professor Ebeling also chairs the Victorian State Committee of the Royal Australasian College of Physicians. He is on the Editorial Board of the Journal of Bone and Mineral Research and of Reumatología Clínica. He is Honorary Editor of Osteoblast and a member of the Medical and Scientific Committee of Osteoporosis Australia.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Diabetes & Endocrinology > Bone & Mineral Metabolism (since 22 January 2007)

Links

http://www.medrmhwh.unimelb.edu.au/staff/academic/ebeling.html

All recent recommendations

• 8.0
  Multiple genetic loci for bone mineral density and fractures.
  Recommended by Peter Ebeling with Dr Claudia Gagnon, Robert Plenge
  
• 6.0
  Effects of Two Years of Daily Teriparatide Treatment on Bone Mineral Density in Postmenopausal Women with Severe Osteoporosis with and without Prior Antiresorptive Treatment.
  Recommended by Peter Ebeling with Claudia Gagnon
  
• 6.5
  Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
  Recommended by Peter Ebeling with Claudia Gagnon, Peter Fuller, Caroline Silve
  
• 3.0
  Calcifications in the abdominal aorta predict fractures in men: MINOS study.
  Recommended by Peter Ebeling
  
• 6.0
  Effects of intravenous zoledronic Acid once yearly on bone remodeling and bone structure.
  Recommended by Peter Ebeling with Claudia Gagnon
  
• 3.0
  Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study.
  Recommended by Peter Ebeling
  
• 6.0
  Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.
  Recommended by Peter Ebeling
  
• 6.0
  Possible association between diabetes and bisphosphonate-related jaw osteonecrosis.
  Recommended by Peter Ebeling
  
• 3.0
  PTH stimulates bone formation in mice deficient in Lrp5.
  Recommended by Peter Ebeling
  
• 3.0
  ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae.
  Recommended by Peter Ebeling